Voyageur Pharmaceuticals Ltd
XTSX:VM

Watchlist Manager
Voyageur Pharmaceuticals Ltd Logo
Voyageur Pharmaceuticals Ltd
XTSX:VM
Watchlist
Price: 0.12 CAD 9.09% Market Closed
Market Cap: CA$21.4m

Voyageur Pharmaceuticals Ltd
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Voyageur Pharmaceuticals Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Voyageur Pharmaceuticals Ltd
XTSX:VM
Total Liabilities
CA$2.2m
CAGR 3-Years
79%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Total Liabilities
$26.9B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Total Liabilities
$51.4m
CAGR 3-Years
16%
CAGR 5-Years
24%
CAGR 10-Years
33%
K
Knight Therapeutics Inc
TSX:GUD
Total Liabilities
CA$279m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
45%
Spectral Medical Inc
TSX:EDT
Total Liabilities
CA$75.8m
CAGR 3-Years
73%
CAGR 5-Years
54%
CAGR 10-Years
38%
Cipher Pharmaceuticals Inc
TSX:CPH
Total Liabilities
$33.6m
CAGR 3-Years
37%
CAGR 5-Years
20%
CAGR 10-Years
-4%
No Stocks Found

Voyageur Pharmaceuticals Ltd
Glance View

Market Cap
21.4m CAD
Industry
N/A

Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The firm is focused on the development of barite and iodine Active Pharmaceutical Ingredients (API) and imaging contrast agents for the medical radiology marketplace. The company owns a 100% interest in three barium sulfate (barite) projects. The firm operates through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc. The company is focused on developing its barium sulfate project, Frances Creek, in BC, Canada for pharmaceutical barium contrast applications, such as x-radiation, computed tomography scans and magnetic resonance imaging applications. The company also owns mineral brine claims in Utah United States, including Frances Creek, Jubilee Mountain and Pedley Mountain.

VM Intrinsic Value
0.002 CAD
Overvaluation 98%
Intrinsic Value
Price CA$0.12

See Also

What is Voyageur Pharmaceuticals Ltd's Total Liabilities?
Total Liabilities
2.2m CAD

Based on the financial report for Aug 31, 2025, Voyageur Pharmaceuticals Ltd's Total Liabilities amounts to 2.2m CAD.

What is Voyageur Pharmaceuticals Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
21%

Over the last year, the Total Liabilities growth was 61%. The average annual Total Liabilities growth rates for Voyageur Pharmaceuticals Ltd have been 79% over the past three years , 21% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett